These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6153939)

  • 1. Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.
    Faxon DP; Creager MA; Halperin JL; Gavras H; Coffman JD; Ryan TJ
    Circulation; 1980 May; 61(5):925-30. PubMed ID: 6153939
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN; Levine TB
    Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Gavras H; Faxon DP; Berkoben J; Brunner HR; Ryan TJ
    Circulation; 1978 Nov; 58(5):770-6. PubMed ID: 699246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
    Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.
    Curtiss C; Cohn JN; Vrobel T; Franciosa JA
    Circulation; 1978 Nov; 58(5):763-70. PubMed ID: 699245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure.
    Vrobel TR; Cohn JN
    Am J Cardiol; 1980 Feb; 45(2):331-6. PubMed ID: 6153497
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
    Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ
    J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274
    [No Abstract]   [Full Text] [Related]  

  • 9. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure.
    Bellissant E; Annane D; Pussard E; Thuillez C; Giudicelli JF
    Fundam Clin Pharmacol; 1996; 10(2):127-35. PubMed ID: 8737955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug suppression of the angiotensin system in congestive heart failure.
    Sullivan JM
    Annu Rev Med; 1983; 34():169-77. PubMed ID: 6190432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease.
    Faxon DP; Creager MA; Halperin JL; Sussman HA; Gavras H; Ryan TJ
    Int J Cardiol; 1982; 2(2):251-62. PubMed ID: 6185446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the renin-angiotensin system in blood pressure regulation. The cardiovascular effects of converting enzyme inhibition in normotensive subjects.
    Niarchos AP; Pickering TG; Case DB; Sullivan P; Laragh JH
    Circ Res; 1979 Dec; 45(6):829-37. PubMed ID: 498446
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
    VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP
    Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension.
    Niarchos AP; Pickering TG; Wallace JM; Case DB; Laragh JH
    Clin Pharmacol Ther; 1980 Nov; 28(5):592-601. PubMed ID: 6160013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
    Levine TB; Franciosa JA; Cohn JN
    Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
    [No Abstract]   [Full Text] [Related]  

  • 20. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ; Laragh JH; Atlas SA; Case DB
    J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.